Premier Veterinary Group – Orland Park
  • 24-HR ER: 708-388-3771
  • Our Services
    • Blood Bank
    • Diagnostic Imaging
    • Emergency Care
    • Internal Medicine
    • Surgery
  • For Your Pet
    • Client Registration Form
    • Get in Line
    • When Your Pet is a Patient
    • Client Portal
    • Prescription Refill
    • Payment Options
    • Pet Insurance
    • End of Life Arrangements
      • Grief Resources
    • Clinical Studies
  • For Veterinary Teams
    • Submit Referrals
    • Referral Process
    • At a Glance
    • Ethos Materials for Clinics
    • Clinical Studies
    • VetBloom CE
    • Continuing Education
  • About Us
    • Our Hospital
    • Our Team
    • Why Ethos
    • Ethos Discovery
    • Contact Us
  • Blogs & Videos
    • Our Blogs
    • PAWEDcasts
  • We’re Hiring!
    • Apply Today
    • Ethos Job Fairs
    • Benefits and Perks
    • Veterinary Training Programs
Premier Veterinary Group – Orland Park
  • Our Services
    • Blood Bank
    • Diagnostic Imaging
    • Emergency Care
    • Internal Medicine
    • Surgery
  • For Your Pet
    • Client Registration Form
    • Get in Line
    • When Your Pet is a Patient
    • Client Portal
    • Prescription Refill
    • Payment Options
    • Pet Insurance
    • End of Life Arrangements
      • Grief Resources
    • Clinical Studies
  • For Veterinary Teams
    • Submit Referrals
    • Referral Process
    • At a Glance
    • Ethos Materials for Clinics
    • Clinical Studies
    • VetBloom CE
    • Continuing Education
  • About Us
    • Our Hospital
    • Our Team
    • Why Ethos
    • Ethos Discovery
    • Contact Us
  • Blogs & Videos
    • Our Blogs
    • PAWEDcasts
  • We’re Hiring!
    • Apply Today
    • Ethos Job Fairs
    • Benefits and Perks
    • Veterinary Training Programs
  • 24-HR ER: 708-388-3771

Clinical Studies

  • Evaluating the Tolerability of Combination of Verdinexor and Doxorubicin in Dogs with Cancer

    Closed

    Verdinexor is a chemotherapy drug that has been conditionally approved by the FDA for the treatment of canine lymphoma. Verdinexor is a selective inhibitor of nuclear export (SINE) compound, and this family of drug has demonstrated encouraging results in preclinical studies when combined with other chemotherapeutic drugs.

    Study Details
  • Ethos Precision Medicine Umbrella Study for Hemangiosarcoma (Ethos-PUSH)

    Open

    Is your dog undergoing surgery for a ruptured splenic tumor? Ethos Discovery would love to have you and your dog participate in our clinical trial! We are evaluating drugs for the treatment of HSA with the goal of curing this aggressive cancer.

    Study Details
  • Dysbiosis Enhancing Linkage Towards Association with Canine Osteosarcoma (DEL-TACO Lite)

    Open

    This study aims to determine whether or not canine patients diagnosed with canine osteosarcoma (OSA) have intestinal dysbiosis and whether treating intestinal disease improves patient outcomes.

    Study Details
Premier Veterinary Group – Orland Park
708-388-3771 | 7000 W. 159th St. Orland Park, IL 60462
  • 24-HR ER: 708-388-3771
  • Our Services
    • Blood Bank
    • Diagnostic Imaging
    • Emergency Care
    • Internal Medicine
    • Surgery
  • For Your Pet
    • Client Registration Form
    • Get in Line
    • When Your Pet is a Patient
    • Client Portal
    • Prescription Refill
    • Payment Options
    • Pet Insurance
    • End of Life Arrangements
      • Grief Resources
    • Clinical Studies
  • For Veterinary Teams
    • Submit Referrals
    • Referral Process
    • At a Glance
    • Ethos Materials for Clinics
    • Clinical Studies
    • VetBloom CE
    • Continuing Education
  • About Us
    • Our Hospital
    • Our Team
    • Why Ethos
    • Ethos Discovery
    • Contact Us
  • Blogs & Videos
    • Our Blogs
    • PAWEDcasts
  • We’re Hiring!
    • Apply Today
    • Ethos Job Fairs
    • Benefits and Perks
    • Veterinary Training Programs
© 2023 Premier Veterinary Group – Orland Park
Website Design by Jackrabbit